重度烧伤患者隐匿性输血相关过敏性休克的识别与诊断分析-附1例报告

杨渝钧 ,  张嵘 ,  尹文 ,  王文婷

中国输血杂志 ›› 2026, Vol. 39 ›› Issue (9) : 1290 -1294.

PDF (1228KB)
中国输血杂志 ›› 2026, Vol. 39 ›› Issue (9) : 1290 -1294. DOI: 10.13303/j.cjbt.issn.1004-549x.2026.09.019
个例报告

重度烧伤患者隐匿性输血相关过敏性休克的识别与诊断分析-附1例报告

作者信息 +

Identification and diagnostic analysis of occult transfusion-related anaphylactic shock in a patient with severe burns: a case report

Author information +
文章历史 +
PDF (1257K)

摘要

目的 通过回顾性病例分析,探讨重度烧伤患者输血相关过敏性休克的临床特点与诊断难点,为提高对此类非典型反应的识别与救治效率提供参考。方法 回顾性分析 1 例重度烧伤(60% TBSA)患者术中输注血浆后发生严重过敏性休克的病例资料。 通过输血反应实验室调查(包括血型复核、不规则抗体筛查、Coombs 试验等) 排除溶血性输血反应及血型不合,结合患者无典型皮肤过敏体征、常规升压治疗无效,而抗过敏治疗(肾上腺素+糖皮质激素)迅速逆转病情的临床过程,确立诊断并总结识别路径。结果 患者输注血浆后迅速出现重度低血压(50/ 40 mmHg)伴意识模糊,心率增快休克表现,但受全身大面积烧伤创面影响,未见典型荨麻疹、皮肤潮红等过敏体征。 经快速补液及常规升压药治疗后血压仍无法维持,紧急给予肾上腺素联合糖皮质激素冲击治疗后,血压迅速回升,生命体征趋于稳定,后续输血前预防性给予抗过敏药物,未再发生类似不良反应。结论 重度烧伤可掩盖输血过敏性休克的皮肤体征,导致诊断延迟。 对常规抗休克无效的输血后低血压患者,“抗过敏治疗有效” 可作为逆向诊断依据。 建议建立以输血后 15 min 内血流动力学监测为核心的预警机制及个体化预防方案,以提升高危患者的输血安全性。

Abstract

Objective To explore the occult clinical features and diagnostic difficulties of transfusion-related anaphylactic shock (TRAS) in patients with severe burns through a retrospective case analysis, and to provide practical references for improving the early identification and treatment efficiency of such atypical allergic reactions. Methods The clinical data of a patient with severe burns (60% TBSA) who developed severe anaphylactic shock after intraoperative plasma transfusion were retrospectively analyzed. Transfusion reaction laboratory investigations, including blood group re-verification, unexpected antibody screening, and the Coombs test, were performed to rule out hemolytic transfusion reactions and blood group incompatibility. Together with the patient's lack of typical cutaneous allergic signs, ineffective response to conventional vasopressor therapy, and the rapid reversal of the condition following anti-allergic treatment (epinephrine plus glucocorticoids), the diagnosis was established and the recognition pathway was summarized. Results Immediately after plasma transfusion, the patient developed severe hypotension (50/ 40 mmHg) accompanied by altered mental status, tachycardia, and shock manifestations. Because of the extensive burn wounds over the whole body, typical allergic signs such as urticaria and skin flushing were not observed. Blood pressure could not be maintained after rapid fluid resuscitation and conventional vasopressor therapy, but recovered rapidly after switching to epinephrine combined with glucocorticoid pulse therapy, and vital signs tended to be stable. Prophylactic anti-allergic drugs were administered before subsequent transfusions, and no similar adverse reactions occurred. Conclusion Transfusion-related allergic reactions in patients with severe burns are characterized by occult clinical manifestations, with skin signs often masked by burn wounds, which can easily lead to diagnostic delay. Reverse verification through the rapid response to anti-allergic therapy after failure of conventional anti-shock treatment is a key clinical approach for identifying atypical anaphylactic shock. It is recommended to establish an early warning mechanism focusing on hemodynamic monitoring within 15 minutes after transfusion, and develop individualized transfusion protocols, including preoperative allergic history assessment and prophylactic anti-allergic medication, for patients with severe burns, so as to enhance transfusion safety in this high-risk population.

关键词

重度烧伤 / 输血治疗 / 过敏反应 / 过敏性休克

Key words

severe burns / blood transfusion therapy / allergic reaction / anaphylactic shock

引用本文

引用格式 ▾
杨渝钧,张嵘,尹文,王文婷. 重度烧伤患者隐匿性输血相关过敏性休克的识别与诊断分析-附1例报告[J]. 中国输血杂志, 2026, 39(9): 1290-1294 DOI:10.13303/j.cjbt.issn.1004-549x.2026.09.019

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

张秋会,孙文利,安群星,等. 大面积烧伤患者反复输血输液抗感染治疗对输血血清学的影响[J].临床输血与检验,2018,20(6):585-587.

[2]

ZHANG Q H, SUN W L, AN Q X, et al. The influencing of multiple transfusions and antibiotic administrations on cross matching of blood in patients with extensive burns[J].J Clin Transfus Lab Med, 2018, 20(6):585-587.

[3]

SAVINKINA A A, HAASS K A, SAPIANO M R P, et al. Transfusion-associated adverse events and implementation of blood safety measures -findings from the 2017 National Blood Collection and Utilization Survey[J].Transfusion,2020,60(Suppl 2):S10-S16.

[4]

KRACALIK I, MOWLA S, BASAVARAJU S V, et al. Transfusion-related adverse reactions:data from the national healthcare safety network hemovigilance module-United States, 2013-2018[J].Transfusion,2021,61(5):1424-1434.

[5]

HAYAT H, AHMED Q, ALAM H, et al. Non-severe allergic transfusion reaction:A hidden cause of wastage of blood product and laboratory resources[J].Vox Sang, 2023,118(3):193-198.

[6]

WAPPLER-GUZZETTA E A, SHAFIQ A, ASAD U, et al. History matters:Preventing severe allergic transfusion reactions[J].Am J Clin Pathol, 2025,164 (4):626-633.

[7]

孙林利,刘丽红,向路艳,等. 2023 版美国烧伤协会《烧伤休克复苏临床实践指南》解读[J].中华烧伤与创面修复杂志,2024,40(10):996-1000.

[8]

SUN L L, LIU L H, XIANG L Y, et al. Interpretation of the 2023 American burn association " Clinical practice guidelines for burn shock resuscitation "[J].Chin J Burns Wounds, 2024,40(10):996-1000.

[9]

HIRAYAMA F, KUROISHI A, MATSUYAMA N, et al. Recent progress in understanding of allergic transfusion reaction[J].Curr Opin Immunol,2025,96:102644.

[10]

王艺媛,张丽娟,杨楠,等. 术中输血相关低血压反应 1 例并文献复习[J].国际检验医学杂志, 2022, 43(15):1917-1920.

[11]

WANG Y Y, ZHANG L J, YANG N, et al. One case of intraoperative transfusion-related hypotensive reaction and literature review[J].Int J Lab Med, 2022, 43(15):1917-1920.

[12]

AMANO Y, FUJII T, TAMURA T, et al. Timing of onset of intraoperative transfusion anaphylaxis:a literature review[J].Nagoya J Med Sci,2024,86(3):351-360.

[13]

中国康复医学会变态反应性疾病康复专业委员会,中华医学会变态反应学分会过敏原特异性诊断学组,中华预防医学会过敏病预防与控制专业委员会,等. 严重过敏反应诊断和临床管理专家共识[J].中华预防医学杂志,2025,59(6):749-765.

[14]

Chinese Rehabilitation Medicine Association Committee on Rehabilitation of Allergic Diseases, Chinese Medical Association Society of Allergology Allergen Specific Diagnostics Group, Chinese Preventive Medicine Association Committee on Allergy Prevention and Control,et al. Expert consensus on the diagnosis and clinical management of anaphylaxis[J].Chin J Prev Med, 2025, 59(6):749-765.

[15]

SHI S, HAN J, YAO Y, et al. Successful prevention of severe allergic transfusion reactions with omalizumab[J].Transfusion,2020,60(7):1639-1642.

[16]

莫秋红,刘学军,刘艺,等. IgA 缺乏型过敏性输血反应及防治策略[J].中国输血杂志,2024,37 (6):705-709.

[17]

MO Q H, LIU X J, LIU Y, et al. IgA deficiency allergic transfusion reaction and its prevention and treatment strategies[J].Chin J Blood Transfusion, 2024, 37(6):705-709.

[18]

KIANI-ALIKHAN S, YONG P F, GROSSE-KREUL D, et al. Successful desensitization to immunoglobulin A in a case of transfusion-related anaphylaxis[J].Transfusion,2010,50(9):1897-18901.

[19]

SALAMA A, KARDASHI R, ARBACH O. Long-term treatment and transfusion of normal blood components following tolerance induction in patients with anti-IgA anaphylactic reactions[J].Transfus Med Hemother,2014,41(5):381-387.

[20]

MCGONIGLE A M, PATEL E U, WATERS K M, et al. Solvent detergent treated pooled plasma and reduction of allergic transfusion reactions[J].Transfusion,2020,60(1):54-61.

[21]

吕红娟,朱海峰,等. 稀有血型筛选用小鼠单克隆抗体的制备及鉴定[J].中国输血杂志,2010,23(6):429-433.

[22]

LÜ H J, ZHU H F, et al. Preparation and identification of murine monoclonal antibodies for the antigen screening of rare donors[J].Chin J Blood Transfusion,2010,23(6):429-433.

[23]

左琴琴,张良子,吴大洲,等. ABO 血型鉴定中人源抗体的应用与评价[J].中国输血杂志,2023,36(10):928-931.

[24]

ZUO Q Q, ZHANG L Z, WU D Z, ET AL. Application and evaluation of human antibodies in ABO grouping[J].Chin J Blood Transfusion,2023,36(10):928-931.

[25]

PATENAUDE S I, SETO N O L, BORISOVA S N, et al. The structural basis for specificity in human ABO (H) blood group biosynthesis[J].Nat Struct Biol, 2002, 9(9):685-690.

基金资助

空军军医大学西京医院助推专项(XJZT25JS19)

AI Summary AI Mindmap
PDF (1228KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉